3AHR

Inactive human Ero1

Summary for 3AHR

• Entry DOI: 10.2210/pdb3ahr/pdb
• Related: 1RP4 3AHQ
• Descriptor: ERO1-like protein alpha, FLAVIN-ADENINE DINUCLEOTIDE (2 entities in total)
• Functional Keywords: disulfide bond, pdi, redox, er, oxidoreductase
• Biological source: Homo sapiens (human)
• Cellular location: Endoplasmic reticulum membrane; Peripheral membrane protein; Lumenal side: Q96HE7
• Total number of polymer chains: 1
• Total formula weight: 54958.38

Authors

Inaba, K.,Sitia, R.,Suzuki, M. (deposition date: 2010-04-26, release date: 2010-12-22, Last modification date: 2024-10-30)

Primary citation

Inaba, K.,Masui, S.,Iida, H.,Vavassori, S.,Sitia, R.,Suzuki, M.
Crystal structures of human Ero1-alpha reveal the mechanisms of regulated and targeted oxidation of PDI
Embo J., 29:3330-3343, 2010

PubMed Abstract: In the endoplasmic reticulum (ER) of eukaryotic cells, Ero1 flavoenzymes promote oxidative protein folding through protein disulphide isomerase (PDI), generating reactive oxygen species (hydrogen peroxide) as byproducts. Therefore, Ero1 activity must be strictly regulated to avoid futile oxidation cycles in the ER. Although regulatory mechanisms restraining Ero1α activity ensure that not all PDIs are oxidized, its specificity towards PDI could allow other resident oxidoreductases to remain reduced and competent to carry out isomerization and reduction of protein substrates. In this study, crystal structures of human Ero1α were solved in its hyperactive and inactive forms. Our findings reveal that human Ero1α modulates its oxidative activity by properly positioning regulatory cysteines within an intrinsically flexible loop, and by fine-tuning the electron shuttle ability of the loop through disulphide rearrangements. Specific PDI targeting is guaranteed by electrostatic and hydrophobic interactions of Ero1α with the PDI b'-domain through its substrate-binding pocket. These results reveal the molecular basis of the regulation and specificity of protein disulphide formation in human cells.

PubMed: 20834232
DOI: 10.1038/emboj.2010.222

Experimental method

X-RAY DIFFRACTION (3.07 Å)